Canada markets open in 7 hours 2 minutes

Vanda Pharmaceuticals Inc. (VNDA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
5.36-0.12 (-2.19%)
At close: 04:00PM EDT
5.07 -0.29 (-5.41%)
After hours: 07:54PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 311.94M
Enterprise Value -66.92M
Trailing P/E 134.00
Forward P/E 30.30
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.60
Price/Book (mrq)0.57
Enterprise Value/Revenue -0.35
Enterprise Value/EBITDA 6.12

Trading Information

Stock Price History

Beta (5Y Monthly) 0.78
52-Week Change 3-13.55%
S&P500 52-Week Change 325.59%
52 Week High 36.76
52 Week Low 33.30
50-Day Moving Average 34.36
200-Day Moving Average 34.42

Share Statistics

Avg Vol (3 month) 32.43M
Avg Vol (10 day) 31.46M
Shares Outstanding 558.2M
Implied Shares Outstanding 658.62M
Float 852.23M
% Held by Insiders 12.99%
% Held by Institutions 188.81%
Shares Short (Apr 15, 2024) 42.07M
Short Ratio (Apr 15, 2024) 40.57
Short % of Float (Apr 15, 2024) 44.53%
Short % of Shares Outstanding (Apr 15, 2024) 43.60%
Shares Short (prior month Mar 15, 2024) 43M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 1.30%
Operating Margin (ttm)-15.67%

Management Effectiveness

Return on Assets (ttm)-1.36%
Return on Equity (ttm)0.47%

Income Statement

Revenue (ttm)192.64M
Revenue Per Share (ttm)3.36
Quarterly Revenue Growth (yoy)-29.80%
Gross Profit (ttm)N/A
EBITDA -10.94M
Net Income Avi to Common (ttm)2.51M
Diluted EPS (ttm)0.04
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)388.26M
Total Cash Per Share (mrq)6.75
Total Debt (mrq)9.4M
Total Debt/Equity (mrq)1.73%
Current Ratio (mrq)4.94
Book Value Per Share (mrq)9.47

Cash Flow Statement

Operating Cash Flow (ttm)12.8M
Levered Free Cash Flow (ttm)-88.78M